BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Hemophilia Alliance - ECPv6.3.7//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Hemophilia Alliance
X-ORIGINAL-URL:https://hemoalliance.org
X-WR-CALDESC:Events for Hemophilia Alliance
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250403T140000
DTEND;TZID=America/New_York:20250403T150000
DTSTAMP:20260515T054559
CREATED:20250306T155911Z
LAST-MODIFIED:20250306T155911Z
UID:70300-1743688800-1743692400@hemoalliance.org
SUMMARY:🟥 Member Webinar : Hemophilia Alliance Hosts - A webinar from Novo Nordisk on Alhemo (concizumab-mtci): A new option for patients living with hemophilia A or B with inhibitors
DESCRIPTION:Date: Thursday\, April 3rd\, 2025\nTime: 2:00pm – 3:00pm ET \n \n  \n  \n  \n  \n \nWEBINAR TOPIC: \nAlhemo (concizumab-mtci): A new option for patients living with hemophilia A or B with inhibitors \nOBJECTIVE: \nTo provide a prescribing information overview of the recently FDA approved medication\, Alhemo (concizumab-mtci)\, for patients living with hemophilia A or B with inhibitors. \nINTENDED AUDIENCE: \nAll HTC staff \nSPEAKER: \nCraig Schmidt\, PharmD\, Medical Accounts Associate Director – Novo Nordisk Medical Affairs\n \nBefore joining Novo Nordisk\, Craig had been in the Community Pharmacy and Managed Care settings for 13 years and held various roles and leadership positions. Of note\, Craig was the Pharmacy Director of a Regional Health Plan that served over a million Medicaid\, Medicare\, and Commercially insured patients within the New York Metro area. \nCraig currently serves as a Medical Accounts Director for Novo Nordisk\, a global healthcare company with 100 years of innovation and leadership in diabetes\, obesity\, and rare disease care. Craig is responsible for providing scientific support to payers\, specialty pharmacies\, and other stakeholders that advance the care for patients living with rare diseases. \nCraig earned his Doctor of Pharmacy from St. John’s University\, and is currently based out of Queens\, NY. \n 
URL:https://hemoalliance.org/alliance-events/a-webinar-from-novo-nordisk-on-alhemo-concizumab-mtci-a-new-option-for-patients-living-with-hemophilia-a-or-b-with-inhibitors/
CATEGORIES:Members Only,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250427T183000
DTEND;TZID=America/New_York:20250429T153000
DTSTAMP:20260515T054559
CREATED:20240906T150841Z
LAST-MODIFIED:20250206T154325Z
UID:68664-1745778600-1745940600@hemoalliance.org
SUMMARY:🟥 Member Event : 2025 Nurses CE Conference
DESCRIPTION:Date: April 27 – 29\, 2025\nLocation: Orlando\, FL \n\nPlease contact Theresa Parker with any questions regarding this registration at theresa@hemoalliance.org or 727-688-2568.
URL:https://hemoalliance.org/alliance-events/2025-nurses-ce-conference/
CATEGORIES:Members Only
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250429T183000
DTEND;TZID=America/New_York:20250501T153000
DTSTAMP:20260515T054559
CREATED:20240906T192120Z
LAST-MODIFIED:20250416T225146Z
UID:68668-1745951400-1746113400@hemoalliance.org
SUMMARY:🟥 Member Event : 2025 New HTC Staff Meeting
DESCRIPTION:Date: April 29 – May 1\, 2025\nLocation: Orlando\, FL \n\nPlease contact Theresa Parker with any questions regarding this registration at theresa@hemoalliance.org or 727-688-2568.
URL:https://hemoalliance.org/alliance-events/2025-new-htc-staff-meeting/
CATEGORIES:Members Only
END:VEVENT
END:VCALENDAR